Emerging Biotech
PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for spec...
February 03, 2023 | News
Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...
February 01, 2023 | News
The global headquarters, R&D center, and TAC are located in the heart of the Biotechnology Park, with a total planned area of 20,029.8 m2. It...
January 31, 2023 | News
Throughout 2022, GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, contributed a significant amo...
January 31, 2023 | News
Bioinformatic experts at Singleron Biotechnologies, a leader in single cell sequencing, have developed a new single cell eQTL analysis workflow that t...
January 26, 2023 | News
The proceeds will be used for general corporate purposes, helping Metabolon further accelerate commercialization activities and continue advancing its well...
January 25, 2023 | News
On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...
January 23, 2023 | News
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...
January 23, 2023 | News
Arab Health to support the next generation of healthcare specialists in the region with the launch of the Future Doctor Programme for undergradua...
January 23, 2023 | News
Cheplapharm were looking for a solution to enable them to move away from manual data processes and using multiple separate systems including Excel, which l...
January 19, 2023 | News
FAPON focuses on three business lines: raw materials and solutions, the IVD ecosystem, and intelligent digital diagnosis & treatment. Supported by its ...
January 17, 2023 | News
The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physi...
January 12, 2023 | News
BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...
January 06, 2023 | News
Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...
January 05, 2023 | News
Most Read
Bio Jobs
News